Australian Clinical Labs slips to record low on half-year profit drop profit drop

Australian Clinical Labs

16/02/2026 24:24

** Shares of Australian Clinical Labs ACL.AX slump 14.1% to their lowest level of A$2.08

** Marks their worst session since late-February, 2025

** Pathology services provider posts half-year profit attributable of A$5.6 million ($3.96 million), down from A$5.6 million last year

** Lowers FY26 underlying EBIT guidance to A$66 million and A$69 million from previous outlook of A$67 million and A$73 million

** Stock is down 20% YTD

($1 = 1.4144 Australian dollars)

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))